Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells

C Fonseca, JN Moreira, CJ Ciudad… - European journal of …, 2005 - Elsevier
The main aim of this work was to develop novel targeted sterically stabilised pH-sensitive
liposomes tailored to promote efficient intracellular delivery of therapeutic molecules into …

Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivo

DD Lasic - Journal of controlled release, 1997 - Elsevier
In the first part, medical applications of liposomes loaded with small molecular weight drugs
is discussed and the use of sterically stabilized liposomes containing doxorubicin in cancer …

[HTML][HTML] Triggered release of doxorubicin following mixing of cationic and anionic liposomes

IV Zhigaltsev, N Maurer, KF Wong, PR Cullis - Biochimica et Biophysica …, 2002 - Elsevier
In many applications, an ability of liposomes to retain drug and then rapidly release it at
some later time would be of benefit. In this work, we investigate the ability of cationic large …

[HTML][HTML] Mechanistic insights into the intracellular release of doxorubicin from pH-sensitive liposomes

SB Dos Reis, J de Oliveira Silva, F Garcia-Fossa… - Biomedicine & …, 2021 - Elsevier
Abstract pH-sensitive liposomes are interesting carriers for drug-delivery, undertaking rapid
bilayer destabilization in response to pH changes, allied to tumor accumulation, a desirable …

Long-circulating (sterically stabilized) liposomes for targeted drug delivery

TM Allen - Trends in pharmacological sciences, 1994 - cell.com
Since their description 30 years ago 1, liposomes (phospholipid bilayer vesicles) have found
widespread use as model membrane systems, and have been extensively investigated for …

Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin

A Bandekar, S Karve, MY Chang, Q Mu, J Rotolo… - Biomaterials, 2012 - Elsevier
pH-triggered lipid-membranes designed from biophysical principles are evaluated in the
form of targeted liposomal doxorubicin with the aim to ultimately better control the growth of …

pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.

P Venugopalan, S Jain, S Sankar, P Singh… - Die …, 2002 - europepmc.org
A growing amount of literature describes the development and applications of novel
targeting and/or release triggering schemes to improve the therapeutic index of drugs …

The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery

RJ Lee, S Wang, MJ Turk, PS Low - Bioscience reports, 1998 - portlandpress.com
Targeted liposomal drug formulations may enter cells by receptor-mediated endocytosis and
then traffick by membrane flow into acidic intracellular compartments. In order to understand …

Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer drug

W Zhang, G Wang, JR Falconer, BC Baguley… - Pharmaceutical …, 2015 - Springer
Purpose To develop a liposomal system with high drug loading (DL) for intravenous (iv)
delivery of a poorly water-soluble basic drug, asulacrine (ASL). Methods A thin-film …

Cell penetrating peptide amphiphile integrated liposomal systems for enhanced delivery of anticancer drugs to tumor cells

M Sardan, M Kilinc, R Genc, AB Tekinay… - Faraday …, 2013 - pubs.rsc.org
Liposomes have been extensively used as effective nanocarriers, providing better solubility,
higher stability and slower release of drugs compared to free drug administration. They are …